IP Library Granted Patent US 7,498,443
Granted Patent B2
US 7,498,443 · App. 10/944,309 · Granted Mar 3, 2009

Process for production of carebastine

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,498,443
App. No.
10/944,309
Granted
Mar 3, 2009
Kind
B2
Abstract

Processes are disclosed for preparing piperidine derivative compounds of the formulae I, II or III:

Claims (22)

1. A process for preparing piperidine derivative compounds of the formula I:

wherein

R 4 is H, alkyl or aryl;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, fluorine, chlorine, alkyl, aryl, hydroxyl, alkoxy, and aryloxy;

said process comprising:

(a) reacting a compound of formula VIa

wherein

X is a group chosen from chlorine, bromine, iodine, —OSO 2 R 5 , and diazonium salt displaceable via oxidative metallic addition; and

LG is a leaving group displaceable by a secondary amine, said leaving group chosen from chlorine, bromine, iodine, and —OSO 2 R 5 , wherein R 5 is chosen from alkyl, fluoroalkyl, aryl, and substituted aryl;

with an isobutyrate equivalent compound of formula IV

wherein R 8 is a trialkylsilyl,

in the presence of a transition metal catalyst having a metal selected from the group comprising of Ni and Pd, and ZnF 2 to provide an α,α-dimethyl-4-acylphenylacetate of the formula VI:

(b) reacting said α,α-dimethyl-4-acylphenylacetate of formula VI with a protected 4-hydroxypiperidine to provide a protected [4-(hydroxy)piperidino]butyrophenone;

(c) deprotecting said protected [4-(hydroxy)piperidino]butyrophenone to provide a [4-(hydroxy)piperidino]butyrophenone of formula XIa

(d) converting the compound of formula XIa to I by reacting with a benzhydryl component of formula XIV;

wherein LG′ is a leaving group displaceable by OH or O ⊖ resulting from the deprotonation of the piperidinyl hydroxyl group of compound XIa.

2. A process according to claim 1 for preparing carebastine wherein a compound of formula XIab

is reacted, in the presence of a base, with a benzhydryl component of formula XIVa;

wherein LG′ is a leaving group, said leaving group chosen from chlorine, bromine, iodine, and —OSO 2 R 5 , wherein R 5 is chosen from alkyl, fluoroalkyl, aryl, and substituted aryl, displaceable by OH or O ⊖ resulting from the deprotonation of the piperidinyl hydroxyl group of compound XIab, and carrying out further process steps to provide carebastine.

3. A process according to claim 1 wherein X is displaced by the isobutryate equivalent compound of formula IV by reaction in the presence of a phosphorus compound chosen from trialkyl phosphine, triaryl phosphine, and mixed alkyl/aryl phosphine, and the transition metal catalyst.

4. A process according to claim 1 wherein R 8 is a trimethylsilyl group.

5. A process according to any of claims 1 or 2 wherein LG′ is chosen from iodine, bromine, chlorine, methanesulfonate, toluenesulfonate, and triflate.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI RENESSELAER, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 028078/0227 →
TERMINATION Recorded Apr 19, 2012
From: BANK OF AMERICA, N.A.
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.; AMRI RENESSELAER, INC.
Reel/Frame 028072/0335 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 6, 2011
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI RENSSELAER, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026397/0001 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 022092/0512 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2005
From: MECKLER, HAROLD; LITTLER, BENJAMIN J.; RAJE, PRASAD; VAN BRUNT, MICHAEL; VOGT, PAUL F.
To: AMR TECHNOLOGY, INC.
Reel/Frame 016199/0918 →